Effects of empagliflozin on nondiabetic salt-sensitive hypertension in uninephrectomized rats
Authors:
Open Access
- 19 September 2019
- journal article
- research article
- Published by Springer Nature in Hypertension Research
- Vol. 42 (12) , 1905-1915
Abstract
Impaired pressure natriuresis (PN) underlies salt-sensitive hypertension, and renal inflammation and hypoxia-inducible factor-1 (HIF-1) have been implicated in the modulation of systemic hypertension. Although sodium–glucose cotransporter-2 (SGLT2) inhibitors were reported to lower blood pressure (BP) in type 2 diabetes mellitus, whether they have a role in nondiabetic hypertensive kidney diseases is unclear. The present study was undertaken to investigate whether nondiabetic salt-sensitive hypertension and accompanying renal inflammation are ameliorated by SGLT2 inhibition. Male Sprague-Dawley rats were randomly divided into three groups: sham controls (SCs), uninephrectomized controls (UCs), and empagliflozin-treated rats (ETs). All rats were fed a rodent diet with 8% NaCl throughout the study period. Empagliflozin was orally administered for 3 weeks after uninephrectomy. Systolic blood pressure was recorded weekly, and kidneys were harvested for immunoblotting, immunohistochemistry, and quantitative PCR analysis at the end of the animal experiment. Systolic BP was significantly decreased in ETs that were orally given empagliflozin for 3 weeks after uninephrectomy. Although ETs did not show any increase in weekly measured urine sodium, the right-shifted PN relationship in UCs was improved by empagliflozin treatment. The expression of HIF-1α was increased in the renal outer medulla of ETs. Consistent with this, HIF prolyl-hydroxylase-2 protein and mRNA were decreased in ETs. The abundance of CD3 and ED-1 immunostaining in UCs was reduced by empagliflozin treatment. The increased IL-1ß, gp91phox, and NOX4 mRNA levels in UCs were also reversed. Empagliflozin restored impaired PN in nondiabetic hypertensive kidney disease in association with increased renal medullary expression of HIF-1α and amelioration of renal inflammation.Keywords
This publication has 41 references indexed in Scilit:
- Renal medullary endothelin-1 is decreased in Dahl salt-sensitive ratsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2011
- Renal inflammation, autoimmunity and salt‐sensitive hypertensionClinical and Experimental Pharmacology and Physiology, 2011
- Reactive Oxygen Species, NADPH Oxidases, and HypertensionHypertension, 2010
- Hypoxia-Inducible Factor Prolyl-Hydroxylase 2 Senses High-Salt Intake to Increase Hypoxia Inducible Factor 1α Levels in the Renal MedullaHypertension, 2010
- Salt-Sensitive Hypertension Induced by Decoy of Transcription Factor Hypoxia-Inducible Factor-1α in the Renal MedullaCirculation Research, 2008
- NITRIC OXIDE AND SUPEROXIDE INTERACTIONS IN THE KIDNEY AND THEIR IMPLICATION IN THE DEVELOPMENT OF SALT‐SENSITIVE HYPERTENSIONClinical and Experimental Pharmacology and Physiology, 2007
- The Kidney, Hypertension, and ObesityHypertension, 2003
- Shiga toxin induces medullary tubular injury in isolated perfused rat kidneysFEMS Immunology & Medical Microbiology, 1997
- Tamm-Horsfall glycoprotein in streptozotocin diabetic rats: a study of kidney in situ hybridization, immunohistochemistry, and urinary excretionDiabetologia, 1995
- Effect of Changes in Salt Intake on Arterial Pressure and Renal Function in Partially Nephrectomized DogsCirculation Research, 1963